Financials in USD. Standardized financial statements.
A compact view of how ONE Bio Corp. turns revenue into operating income and net income.
| Metric | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|
| Revenue? | $52.30M | $22.07M | $78,240 | $578,590 | $207,507 | $163,782 |
| Revenue Growth? | +136.9% | +28112.2% | -86.5% | +178.8% | +26.7% | 0.0% |
| Cost of Revenue? | $32.17M | $12.09M | $43,906 | $194,869 | $69,000 | $25,373 |
| Gross Profit? | $20.13M | $9.98M | $34,334 | $383,721 | $138,505 | $138,409 |
| Gross Margin? | +38.5% | +45.2% | +43.9% | +66.3% | +66.7% | +84.5% |
| Operating Expenses? | $6.44M | $2.53M | $68,599 | $340,866 | $149,864 | $189,856 |
| Operating Income? | $13.68M | $7.46M | -$34,265 | $42,855 | -$11,359.65 | -$51,446.91 |
| EBITDA? | $13.61M | $8.02M | -$25,256 | -$4,382.27 | $132,324 | $49,810 |
| Income Before Tax | $12.24M | $7.41M | -$42,136 | $42,855 | -$3,635.14 | $17,345 |
| Income Tax Expense | $3.28M | $2.03M | $0 | $5,597.12 | $154 | $0 |
| Net Income? | $8.68M | $4.77M | -$42,136 | $37,258 | -$3,789.14 | $17,345 |
| EPS? | $1.43 | $0.95 | $-0.01 | $0.01 | $-0.06 | $0.25 |
| Diluted EPS? | $1.35 | $0.93 | $-0.01 | $-0.01 | $-0.06 | $0.25 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality